Aurinia Pharmaceuticals Inc. (AUPH)
Since May 06, 2021, Aurinia Pharmaceuticals Inc. (AUPH) has reported earnings 21 times. On average the shares move ±10.87% post-earnings, with a positive reaction 57.1% of the time. Its largest post-earnings gain was +25.99% (May 10, 2022) and its largest decline was -31.93% (Nov 03, 2022). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How AUPH moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±10.87%
Positive %
57.1%
Negative %
42.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☀ PRE | +6.19% | open_in_new |
| May 07, 2026 | ☀ PRE | -6.74% | open_in_new |
| Feb 26, 2026 | ☀ PRE | -3.19% | open_in_new |
| Nov 04, 2025 | ☀ PRE | +8.35% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±10.87%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13D/A | 20260826 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| 144 | 20260821 | open_in_new SEC.gov |
| 8-K | 20260819 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
Frequently asked about AUPH earnings
When does Aurinia Pharmaceuticals Inc. report earnings next? expand_more
Aurinia Pharmaceuticals Inc. (AUPH)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AUPH stock move after earnings? expand_more
Over 21 reports, AUPH has moved an average of ±10.87% the session after earnings, closing higher 57.1% of the time.
What was AUPH's biggest post-earnings move? expand_more
AUPH's largest post-earnings gain on record was +25.99% on May 10, 2022, and its largest decline was -31.93% on Nov 03, 2022.
Where can I find Aurinia Pharmaceuticals Inc.'s SEC filings? expand_more
All of Aurinia Pharmaceuticals Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right